or Try an Advanced Search...

    Glucose Meter Stocks List

    Symbol Grade Name % Change
    TNDM D Tandem Diabetes Care, Inc. 1.96
    SNY F Sanofi 0.42
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology

    Related ETFs - A few ETFs which own one or more of the above listed Glucose Meter stocks.

    Symbol Grade Name Weight
    PINK D Simplify Health Care ETF 6.91
    AWEG B Alger Weatherbie Enduring Growth ETF 4.84
    PPH D Market Vectors Pharmaceutical ETF 4.26
    PVAL A Putnam Focused Large Cap Value ETF 2.58
    PID C PowerShares Intl Dividend Achievers 2.51
    View all Glucose Meter ETFs...
    Compare ETFs
    Compare AWEG to PPH Compare AWEG to PVAL Compare PPH to PVAL

        Glucose Meter Stocks Recent News

        Date Stock Title
        Nov 21 TNDM Tandem Diabetes Care Announces Upcoming Conference Presentations
        Nov 20 SNY CDC warns of an imminent spike in COVID, flu cases
        Nov 20 SNY Here’s What Drove Sanofi’s (SNY) Earnings
        Nov 20 SNY Sanofi: Information concerning the total number of voting rights and shares - October 2024
        Nov 18 SNY FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
        Nov 15 SNY How analysts are reacting to RFK Jr. as Trump's HHS pick
        Nov 15 SNY FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
        Nov 15 SNY Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
        Nov 15 SNY Stocks to Watch Friday: Applied Materials, Alibaba, Domino's, Novo Nordisk
        Nov 15 SNY Trump’s RFK Jr. Pick Weighs on Vaccine Makers
        Nov 15 SNY Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
        Nov 15 SNY European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
        Nov 15 SNY EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
        Nov 15 SNY Drugmaker stocks slide as Trump picks vaccine sceptic RFK Jr for US health job
        Nov 15 SNY Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
        Nov 15 SNY Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology
        Glucose Meter

        A glucose meter is a medical device for measuring the amount of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking the skin with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in mg/dl or mmol/l.

        Browse All Tags